Dose-Response (Jan 2010)

Clinical Application of Ischemic Preconditioning in the Elderly

  • Pasquale Abete,
  • Francesco Cacciatore,
  • Gianluca Testa,
  • David Della-Morte,
  • Gianluigi Galizia,
  • Nicola Ferrara,
  • Franco Rengo

DOI
https://doi.org/10.2203/dose-response.09-023.Abete
Journal volume & issue
Vol. 8

Abstract

Read online

A mild stress such as brief ischemic episodes may protect the heart from a successive and more prolonged myocardial ischemia (ischemic preconditioning). This phenomenon is considered a typical “hormetic mechanism” by which the heart is immunized from pathological insults such as myocardial ischemia. This mechanism is reduced with aging and it may be restored and/or preserved by drugs such as adenosine or nicorandil, a mitochondrial K ATP channels, and lifestyle interventions such as physical activity and/or hypocaloric diet. Moreover, since the mechanisms involved in cardiac ischemic preconditioning have been established basic and clinical investigators are encouraged to test several drug in well-controlled animal and human studies in order to prevent and/or restore the age-related reduction of ischemic preconditioning.